Gary Hoyle, PhD
|
Environmental and Occupational Health Sciences Role: Faculty |
Background
Gary W. Hoyle will join the University of Louisville School of Public
Health and Information Sciences as a professor in the Department of
Environmental and Occupational Health Sciences and University Scholar
on August 1, 2007.
Dr. Hoyle was previously a faculty member
in Tulane University’s Department of Medicine, Section of Pulmonary
Disease, Critical Care and Environmental Medicine.
Dr.
Hoyle’s research interests focus on mechanisms of lung injury and
inflammation, including the regulation of lung injury and repair by G
proteins, the role of sensory nerves and nerve growth factor in
environmental and occupational lung disease, and the control of DNA
damage and repair by sensory neuropeptide receptors.
He has more
than 12 years of uninterrupted extramural federal funding from the
National Institutes of Health (NIH), U.S. Environmental Protection
Agency (EPA) and the Department of Defense. He was recently awarded a
$1.3M grant from the NIH to study novel therapies for chlorine gas
exposure. This research will continue at the University of
Louisville.
Dr. Hoyle received his B.A. from Johns Hopkins
University, his Ph.D. in Biochemistry from Duke University, and
completed post-doctoral fellowship training at the University of
Pennsylvania.
Research Interests
Mechanisms of lung injury and inflammation
G protein signaling
Sensory nerves and inflammation
Air pollution and asthma
Nerve growth factor and airway disease
Current Projects
1. Novel therapies for chlorine-induced lung injury. NIH/NIEHS U01 ES015673. Principal Investigator, 9/29/06-5/31/11.
2. Levalbuterol and acute lung injury. Sepracor, Inc. Principal Investigator, 12/7/07-12/6/08.
3. Neuroanatomy and molecular biology of airway neurons. R01 HL035812. Co-investigator (Richard Dey, Principal Investigator), 4/1/07-3/31/12.
4. Role of EBV gene products in the pathogenesis of IPF. NIH/NHLBI R01 HL083901. Co-investigator (Joseph Lasky, Principal Investigator), 5/1/06-4/30/10.
5. Nerve growth factor and asthma.
Recent Publications
Lee, C.-T., Poovey, H. G., Rando, R. J., Friedman, M., and Hoyle, G. W. (2003). An HDI polyisocyanate aerosol exposure system for large-scale animal experiments. Am. Ind. Hyg. Assoc. J. 64:439-444.
Lee, C.-T., Friedman, M., Poovey, H. G., Ie, S. R., Rando, R. J., and Hoyle, G. W. (2003). Pulmonary toxicity of hexamethylene diisocyanate aerosols in mice. Toxicol. Appl. Pharmacol. 188:154-164.
Zhuo, Y., Hoyle G. W., Zhang, J., Morris, G., and Lasky, J. A. (2003). A novel murine PDGF-D splicing variant results in significant differences in peptide expression and function. Biochem. Biophys. Res. Commun. 308:126-132.
Hoyle, G. W. (2003). Neurotrophins and lung disease. Cytokine Growth Factor Rev. 14:551-558.
Vuillemenot, B. R., Rodriguez, J. F., and Hoyle, G. W. (2004). Lymphoid tissue and emphysema in the lungs of transgenic mice inducibly expressing TNF-. Am. J. Resp. Cell Mol. Biol. 30:438-448.
Henson, M. C., Swan, K. F., Edwards, D. E., Hoyle, G. W., Purcell, J., and Castracane, V. D. Leptin receptor expression in fetal lung is enhanced in late gestation in the baboon: a model for human pregnancy. (2004). Reproduction 127:87-94.
Quarcoo, D., Schulte-Herbruggen, O., Lommatzsch, M., Schierhorn, K., Hoyle, G. W., Renz, H., and Braun, A. (2004). Nerve growth factor induces increased airway inflammation via a neuropeptide-dependent mechanism in a transgenic animal model of allergic airway inflammation. Clin. Exp. Allergy 34:1146-1151.
Curiel, T. J., Cheng, P., Mottram, P., Alvarez, X., Moons, L., Evdemon-Hogan, M., Wei, .S, Zou, L., Kryczek, I., Hoyle, G., Lackner, A., Carmeliet, and P., Zou, W. (2004). Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res. 64:5535-5538.
Li, J., Poovey, H. G., Rodriguez, J. F., Brody, A. R., and Hoyle, G. W. (2004). Effect of platelet-derived growth factor on the development and persistence of asbestos-induced fibroproliferative lung disease. J. Environ. Path. Toxicol. Oncol. 23:253-266.
Lee, C.-T., Ylostalo, J., Friedman, M., and Hoyle, G. W. (2005). Gene expression profiling in mouse lung following polymeric hexamethylene diisocyanate exposure. Toxicol. Appl. Pharmacol. 205:53-64.
Zhou, Y., Hoyle, G. W., and Lasky, J. A. (2006). Overexpression of PDGF-C using a lung-specific promoter results in abnormal lung development. Transgenic Res. 15:543-555.
Grad, I., McKee, T. A., Ludwig, S. M., Hoyle, G. W., Ruiz, P., Wurst, W., Floss, T., Miller, C. A., III, and Picard., D. (2006). The Hsp90 co-chaperone p23 is essential for perinatal survival. Mol. Cell. Biol. 26:8976-8983.
Williams, R., Zou, Y., and Hoyle, G. W. (2007). The tachykinin 1 receptor activates NF-B in lung epithelial cells through a Gq-dependent pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L430-L437.
Zwezdaryk, K. J., Coffelt, S. B., Figueroa, Y. G., Liu, J., Phinney, D. G., LaMarca, H. L., Florez, L., Morris, C. B., Hoyle, G. W., and Scandurro, A. B. (2007). Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal cells. Exp. Hematol. 35:640-652.
Lee, C.-T., Poovey, H. G., Rando, R. J., and Hoyle, G. W. (2007). Neuronal modulation of lung injury induced by polymeric hexamethylene diisocyanate in mice. Toxicol. Appl. Pharmacol. 224, 19-28.
Fattman, C., Gambelli, F., Hoyle, G., Pitt, B., and Ortiz, L. (2008). Epithelial expression of TIMP1 does not alter sensitivity to bleomycin-induced lung injuriy in C57BL/6 mice. Am. J. Physiol. Lung Cell. Mol. Physiol. doi:10.1152/ajplung.00291.2007.



